• New Delhi
  • 9 August 2014
  • Reports/White Papers
  • By Rahul Koul

Rotavirus vaccine in UIP to save medical costs, reduce mortality: PHFI study

As per the latest study on the impact of India's introduction of rotavirus vaccine in its immunization program, there will be significant decrease in mortality (9500 deaths/year) and cost savings (roughly $91 million each year)

immunization

Vaccine Boost: This study has used IndiaSim, a simulated agent-based model (ABM) of the Indian population (including socio-economic characteristics and immunization status) and the health system to model three interventions.

A study spearheaded by the Public Health Foundation of India (PHFI) has concluded that improving immunization coverage and the introduction of a rotavirus vaccine significantly alleviates disease and financial burden in Indian households. It also points to the fact that the population subgroups or regions with low existing immunization coverage benefit the most from the intervention.

Therefore, the authors of the study report of 'Analysis of Universal Immunization Program and introduction of rotavirus vaccine in India with Indianisim' have suggested that increasing coverage by targeting those subgroups alleviates the burden, more than simply increasing coverage in the population at large.

As per the report, India has the highest under-five death toll globally, approximately 20 percent of which is attributed to vaccine-preventable diseases. It says that since India's Universal Immunization Program (UIP) is working both to increase immunization coverage and to introduce new vaccines, the authors analyzed how the disease and financial burden was alleviated across India's population (by wealth quintile, rural or urban area, and state) through increasing vaccination rates and introducing a rotavirus vaccine.

The prominent experts, who were involved in the study and authored the study report include Mr Itamar Megiddo, Ms Abigail R Colsona, Mr Arindam Nandia, Ms Susmita Chatterjee, Mr Shankar Prinjad, Mr Ajay Khera, and Mr Ramanan Laxminarayanan. The study was conducted jointly by the Center for Disease Dynamics, Economics and Policy, Washington, DC, USA; Princeton Environmental Institute, Princeton University, Princeton, NJ, USA; Public Health Foundation of India, New Delhi; India School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh and the Ministry of Health and Family Welfare, Government of India, New Delhi,

 

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X